Articles by Suzanne Hodsden
-
West To Build New Manufacturing Facility In Ireland In 2015
10/3/2014
West announced plans to break ground on a $126 million manufacturing facility in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges — a market with growing global demand.
-
MIT’s Needle-Pill Could Replace Injections
10/2/2014
Scientists at MIT and Massachusetts General Hospital have designed a new capsule that could take the place of injections, offering a less complicated and potentially more effective drug-delivery method for insulin and other biologics.
-
Consort Medical To Acquire British CDMO Aesica for $372M
10/1/2014
Consort Medical announced its plans to purchase Aesica, one of Europe’s largest contract manufacturing and development organizations, a move expected to broaden its existing Bespak drug delivery device business. The deal, worth $372M, will depend on the approval of Consort shareholders.
-
$25B Biosimilar Market Set To Boom By 2020
9/30/2014
As more and more licenses for biologics are set to expire, Pharma companies around the globe are scrambling for a share of the biosimilar market.
-
EPIRUS Strikes Deal With China’s Livzon To Develop And Market Biosimilars
9/29/2014
American biopharma company EPIRUS has signed a multi-product deal with China-based Livzon to develop, manufacture, and market a series of biosimilars.
-
Catalent And Cingulate To Collaborate On ADHD Therapies
9/29/2014
Catalent and Cingulate have signed a licensing deal for the development and commercialization of a series of new drugs indicated to treat attention deficit hyperactivity disorder (ADHD) using Catalent’s manufacturing technology.
-
Inovio's DNA-Based Ebola Vaccine To Enter Human Trials By Early 2015
9/25/2014
Inovio Pharmaceuticals in conjunction with vaccine manufacturer GeneOne Life Science announced plans to begin phase I clinical trials on an Ebola vaccine in the first half of 2015. If the phase1 trials prove successful, both companies will seek the support and funding from a third party to further develop and market the vaccine.
-
Medicines Manufacturing Industry Partnership Launched In U.K.
9/24/2014
A new initiative in the U.K., The New Medicines Manufacturing Industry Partnership (MMIP), formed by the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA), aims to boost current innovative drug manufacturing and attract more business to the country.
-
Congress Introduces FAST Generic Act
9/24/2014
Congressmen Steve Stivers (R-OH) and Peter Welch (D-VT) have introduced a bill, the Fair Access for Safe and Timely (FAST) Generics Act, in the hopes of shutting down loopholes in the Risk Evaluation and Mitigation Strategies (REMS), which was introduced in 2007 to allow branded pharmaceutical companies to restrict market access for generic alternatives.
-
Survey Reports Increased Biopharma, Pharma Contract Services Spending In 2014
9/22/2014
The 2014 edition of the PharmSource-Pharmaceutical Technology Outsourcing Survey conducted in June, confirms industry expectations for growth in outsourcing, quells fears about low-cost international competition, and forecasts anothers year of growth for the contract service industry in 2015.